Importantly, CCL2 levels are not linked to the responsiveness of MDS patients to 5-azacytidine chemotherapy [80], indicating that CCL2 may not have an anti-apoptotic effect on MDS cells. Here, CCL2 is linked to myelodysplastic syndrome.